Extracellular vesicles mediated gastric cancer immune response: tumor cell death or immune escape?
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Extracellular vesicles (EVs) play a key role in gastric cancer (GC) progression and immune evasion. This review explores how GC-derived EVs remodel the immune microenvironment and how immune cell-derived EVs impact GC, highlighting their therapeutic potential.
Area Of Science
- Oncology
- Immunology
- Cell Biology
Background
- Gastric cancer (GC) is a leading cause of cancer-related mortality globally, with poor prognosis in advanced stages.
- Current treatment strategies for GC are limited, necessitating novel therapeutic approaches.
- Extracellular vesicles (EVs) are increasingly recognized for their roles in cancer development and progression.
Purpose Of The Study
- To review the multifaceted roles of EVs in gastric cancer (GC).
- To elucidate how GC-derived EVs influence the tumor immune microenvironment.
- To explore the impact of immune cell-derived EVs on GC development and their potential in immunotherapy.
Main Methods
- Literature review of studies investigating extracellular vesicles (EVs) in gastric cancer (GC).
- Analysis of the mechanisms by which GC-derived EVs affect the immune microenvironment.
- Examination of the functions of immune cell-derived EVs in GC pathogenesis and therapeutic applications.
Main Results
- GC-derived EVs contribute to tumor progression by altering the tumor microenvironment and immune response.
- Immune cell-derived EVs can modulate immune function and exhibit anti-tumor capabilities.
- EVs are implicated in GC immune escape and immune microenvironment remodeling.
Conclusions
- EVs are critical mediators in gastric cancer (GC) development, immune escape, and immune microenvironment remodeling.
- Understanding the distinct functions of EVs from different sources is crucial for GC research.
- EVs hold significant promise as diagnostic biomarkers and therapeutic agents in GC immunotherapy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...